GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA
Patient 2
15
mild
346
IgA
Patient 2
15
mild
358
IgA
Patient 2
15
mild
878
IgA
Patient 2
15
mild
533
IgA
Patient 2
15
mild
778
IgA
Patient 2
15
mild
851
IgA
Patient 2
15
mild
455
IgA
Patient 2
15
mild
349
IgA
Patient 2
15
mild
397
IgA
Patient 2
15
mild
357
Displaying entries 111 - 120 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01